Cargando…
The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis
OBJECTIVE AND DESIGN: It has been demonstrated that changes in the normal-appearing white matter (NAWM) in multiple sclerosis precede the appearance of classical lesions. The understanding of NAWM biology in an established disease model might help to clarify why some of them progress to active demye...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SP Birkhäuser Verlag Basel
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125513/ https://www.ncbi.nlm.nih.gov/pubmed/21516513 http://dx.doi.org/10.1007/s00011-011-0339-0 |
_version_ | 1782207229142761472 |
---|---|
author | Kipp, M. Norkus, A. Krauspe, B. Clarner, T. Berger, K. van der Valk, P. Amor, S. Beyer, C. |
author_facet | Kipp, M. Norkus, A. Krauspe, B. Clarner, T. Berger, K. van der Valk, P. Amor, S. Beyer, C. |
author_sort | Kipp, M. |
collection | PubMed |
description | OBJECTIVE AND DESIGN: It has been demonstrated that changes in the normal-appearing white matter (NAWM) in multiple sclerosis precede the appearance of classical lesions. The understanding of NAWM biology in an established disease model might help to clarify why some of them progress to active demyelinating lesions. MATERIAL OR SUBJECTS: C57BL6 male mice (19–21 g) were used in this study. TREATMENT: Demyelination was induced by feeding mice a diet containing 0.2% cuprizone for up to 5 weeks. METHODS: Routine stainings (luxol fast blue, and hematoxylin and eosin) and immunohistochemistry were performed to assess myelin status and the inflammatory infiltrate. RESULTS: We demonstrated that, in the toxic demyelination cuprizone model, the corpus callosum is severely demyelinated after a 5-week cuprizone challenge (acute demyelination) whereas the fimbria of the hippocampus appear normal in routine myelin stainings. Microgliosis but not astrogliosis is evident after acute demyelination in the fimbria. Interestingly, both regions, the fimbria and the corpus callosum, demonstrated early oligodendrocyte apoptosis as well as intense microglia accumulation and activation. However, only the corpus callosum progresses to actively demyelination lesions whereas the fimbria does not. CONCLUSIONS: The applied model appears suitable for elucidating pathways which promote progression of affected tissue to an active lesion. |
format | Online Article Text |
id | pubmed-3125513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | SP Birkhäuser Verlag Basel |
record_format | MEDLINE/PubMed |
spelling | pubmed-31255132011-08-09 The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis Kipp, M. Norkus, A. Krauspe, B. Clarner, T. Berger, K. van der Valk, P. Amor, S. Beyer, C. Inflamm Res Short Communication OBJECTIVE AND DESIGN: It has been demonstrated that changes in the normal-appearing white matter (NAWM) in multiple sclerosis precede the appearance of classical lesions. The understanding of NAWM biology in an established disease model might help to clarify why some of them progress to active demyelinating lesions. MATERIAL OR SUBJECTS: C57BL6 male mice (19–21 g) were used in this study. TREATMENT: Demyelination was induced by feeding mice a diet containing 0.2% cuprizone for up to 5 weeks. METHODS: Routine stainings (luxol fast blue, and hematoxylin and eosin) and immunohistochemistry were performed to assess myelin status and the inflammatory infiltrate. RESULTS: We demonstrated that, in the toxic demyelination cuprizone model, the corpus callosum is severely demyelinated after a 5-week cuprizone challenge (acute demyelination) whereas the fimbria of the hippocampus appear normal in routine myelin stainings. Microgliosis but not astrogliosis is evident after acute demyelination in the fimbria. Interestingly, both regions, the fimbria and the corpus callosum, demonstrated early oligodendrocyte apoptosis as well as intense microglia accumulation and activation. However, only the corpus callosum progresses to actively demyelination lesions whereas the fimbria does not. CONCLUSIONS: The applied model appears suitable for elucidating pathways which promote progression of affected tissue to an active lesion. SP Birkhäuser Verlag Basel 2011-04-24 2011 /pmc/articles/PMC3125513/ /pubmed/21516513 http://dx.doi.org/10.1007/s00011-011-0339-0 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Short Communication Kipp, M. Norkus, A. Krauspe, B. Clarner, T. Berger, K. van der Valk, P. Amor, S. Beyer, C. The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis |
title | The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis |
title_full | The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis |
title_fullStr | The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis |
title_full_unstemmed | The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis |
title_short | The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis |
title_sort | hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125513/ https://www.ncbi.nlm.nih.gov/pubmed/21516513 http://dx.doi.org/10.1007/s00011-011-0339-0 |
work_keys_str_mv | AT kippm thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT norkusa thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT krauspeb thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT clarnert thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT bergerk thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT vandervalkp thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT amors thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT beyerc thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT kippm hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT norkusa hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT krauspeb hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT clarnert hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT bergerk hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT vandervalkp hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT amors hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis AT beyerc hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis |